BDNF and schizophrenia: Nevertheless, although no n−3 PUFA supplementation studies assessing neurotrophin profile have been conducted in schizophrenia patients, the animal studies described strongly support the results of the present study, which indicate increases in BDNF peripheral levels after n−3 PUFA supplementation in first-episode schizophrenia patients.